John L. Lubniewski, Chief Business Officer at HTG MOLECULAR DIAGNOSTICS, INC (HTGM), sold 796 shares at $2.92 ($2K) on 2016-04-04, disclosed to the SEC on 2016-04-05.
Scheduled sale ($2k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.89 | 709 | $2K | 89.0% |
| 2 | $2.92 | 87 | $254 | 11.0% |
| Total | $2.89 avg | 796 | $2K | 100% |
| Filing → |
| HTGM | BUY | 2015-08-12 | $38K | — | Filing → |